Literature DB >> 30256547

Insomnia and Impaired Quality of Life in the United States.

Mark Olfson1,2, Melanie Wall2, Shang-Min Liu2, Charles M Morin3, Carlos Blanco4.   

Abstract

OBJECTIVE: This analysis characterizes the individual-level and population-level burden of insomnia in relation to other medical conditions and describes the comorbidity of insomnia with other medical conditions, including the dependence of these comorbidities on pain, life events, and mental disorders.
METHODS: Information from 34,712 adults in the National Epidemiologic Survey on Alcohol and Related Conditions-III (2012-2013) was analyzed. Quality-adjusted life-years (QALYs) were measured with the SF-6D, a 6-dimensional health state classification derived from the Short-Form-12, version 2.
RESULTS: In the last 12 months, 27.3% of adults reported insomnia. The US annual loss of QALYs associated with insomnia (5.6 million; 95% CI, 5.33-5.86 million) was significantly larger than that associated with any of the other 18 medical conditions assessed, including arthritis (4.94 million; 95% CI, 4.62-5.26 million), depression (4.02 million; 95% CI, 3.87-4.17 million), and hypertension (3.63 million; 95% CI, 3.32-3.93 million). After control for demographic factors, all conditions examined from obesity (adjusted odds ratio [aOR] = 1.25) to mania (aOR = 5.04) were associated with an increased risk of insomnia. Further controlling for pain, stressful life events, and mental disorders decreased the odds of the co-occurrence of insomnia with these conditions. The decrease in insomnia comorbidity associated with pain was greatest for fibromyalgia (31.8%) and arthritis (20.1%); the decrease in insomnia comorbidity associated with life events was greatest for mania (13.4%) and drug use disorders (11.2%); and the decrease in insomnia comorbidity associated with mental disorders was greatest for peptic ulcer disease (11.2%) and liver diseases (11.1%).
CONCLUSIONS: Insomnia is prevalent and associated with substantial population-level burden in self-assessed health. The co-occurrence of insomnia with common medical conditions is differentially related to pain and to a lesser extent to stressful life events and mental disorders. © Copyright 2018 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2018        PMID: 30256547     DOI: 10.4088/JCP.17m12020

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  18 in total

Review 1.  Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia).

Authors:  Amnon A Berger; Emily R Sottosanti; Ariel Winnick; Joseph Keefe; Elasaf Gilbert; Jamal Hasoon; Michael E Thase; Alan D Kaye; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2022-02-25

2.  Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.

Authors:  Jack D Edinger; J Todd Arnedt; Suzanne M Bertisch; Colleen E Carney; John J Harrington; Kenneth L Lichstein; Michael J Sateia; Wendy M Troxel; Eric S Zhou; Uzma Kazmi; Jonathan L Heald; Jennifer L Martin
Journal:  J Clin Sleep Med       Date:  2021-02-01       Impact factor: 4.062

3.  Validation of the Insomnia Severity Index (ISI) for identifying insomnia in young adult cancer survivors: comparison with a structured clinical diagnostic interview of the DSM-5 (SCID-5).

Authors:  Alexis L Michaud; Eric S Zhou; Grace Chang; Christopher J Recklitis
Journal:  Sleep Med       Date:  2021-02-04       Impact factor: 3.492

4.  Diversity of social networks versus quality of social support: Which is more protective for health-related quality of life among older adults?

Authors:  Taeho Greg Rhee; Richard A Marottoli; Joan K Monin
Journal:  Prev Med       Date:  2021-01-28       Impact factor: 4.018

5.  Primary care provider evaluation and management of insomnia.

Authors:  Joy Sun; Miranda V McPhillips; Ker-Cheng Chen; Yinyin Zang; Junxin Li; Jessica Oehlke; Glenna S Brewster; Nalaka S Gooneratne
Journal:  J Clin Sleep Med       Date:  2021-05-01       Impact factor: 4.062

6.  Sleep Disturbance in Patients with Urticaria and Atopic Dermatitis: An Underestimated Burden.

Authors:  Caroline Mann; Matthias Dreher; Hans-Günter Weeß; Petra Staubach
Journal:  Acta Derm Venereol       Date:  2020-03-12       Impact factor: 3.875

7.  ISI-3: evaluation of a brief screening tool for insomnia.

Authors:  Manu Thakral; Michael Von Korff; Susan M McCurry; Charles M Morin; Michael V Vitiello
Journal:  Sleep Med       Date:  2020-08-27       Impact factor: 4.842

8.  Risk factors of persistent insomnia among survivors of traumatic injury: a retrospective cohort study.

Authors:  Zachary A Haynes; Jacob F Collen; Eduard A Poltavskiy; Lauren E Walker; Jud Janak; Jeffrey T Howard; J Kent Werner; Emerson M Wickwire; Aaron B Holley; Lee Ann Zarzabal; Alan Sim; Adi Gundlapalli; Ian J Stewart
Journal:  J Clin Sleep Med       Date:  2021-09-01       Impact factor: 4.324

9.  Prevalence, risk correlates, and health comorbidities of insomnia in US military veterans: results from the 2019-2020 National Health and Resilience in Veterans Study.

Authors:  Simon P Byrne; Elissa McCarthy; Jason C DeViva; Steven M Southwick; Robert H Pietrzak
Journal:  J Clin Sleep Med       Date:  2021-06-01       Impact factor: 4.324

10.  Tobacco cigarette smokers who endorse greater intolerance for nicotine withdrawal also report more severe insomnia symptoms.

Authors:  Emma C Lape; Lisa R LaRowe; Emily L Zale; Les A Gellis; Aesoon Park; Joseph W Ditre
Journal:  Exp Clin Psychopharmacol       Date:  2021-02-25       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.